Cocaine Dependence Clinical Trial
Official title:
Reward Processing in Cocaine Addiction
Background:
- Cocaine affects the brain's ability to process information. However, different people
respond to cocaine in different ways, and differences in brain structure and function may
affect how cocaine alters brain activity. By using functional magnetic resonance imaging
(fMRI) to monitor brain activity during tasks that provide simple rewards, researchers hope
to better understand how the brain responds to rewards and how this response is affected by
drugs like cocaine.
Objectives:
- To determine the effect of cocaine administration on the reward experience in
cocaine-dependent individuals.
- To study genetic and personality factors that may contribute to cocaine dependence.
Eligibility:
- Individuals between 18 and 45 years of age who either are cocaine-dependent and not seeking
treatment or are healthy volunteers.
Design:
- Participants will be asked to avoid consuming alcohol and restrict consumption of
caffeine prior to the study. Participants provide urine and breath samples to be tested
for chemicals that may interfere with the study.
- All participants will complete a training session and at least one fMRI scanning
session. During the training session, participants will be introduced to the reward
tasks and MRI equipment.
- Healthy volunteers will have a single fMRI session that will involve reward tasks to be
completed during the scanning. Rewards will include small amounts of fruit juice and the
opportunity to win money.
- Cocaine-dependent participants will have a training session and three experimental
sessions including 1) a mock MRI scan to test cocaine tolerance, 2) one fMRI scan with
reward tasks after administration of IV cocaine, and 3) one fMRI scan with reward tasks
after administration of IV placebo (saline solution). Rewards will include small amounts
of fruit juice and the opportunity to win money.
- In addition to the scans, participants will provide a blood sample for further study and
will answer questionnaires provided by the researchers.
Objective:
The overall objective of this study is to determine the effect that cocaine administration
has upon the experience of reward in dependent individuals and the contribution of reward
processing (or dysfunction) to the reinforcing effects of cocaine and the recidivism rates
noted in cocaine-dependent individuals. The primary goal is to employ functional magnetic
resonance imaging (fMRI) to ascertain the function of neural systems that respond to cocaine
in human participants and to determine the role that they play in the processing of different
types of rewarding stimuli during episodes where individuals are drug-free and those where
they are under the acute influence of cocaine.
Study Population:
The experimental population for this investigation will be non-treatment seeking,
cocaine-dependent adults (i.e. 18 45 years old). A cohort of healthy, drug-free, individuals,
matched for age, gender, ethnicity and IQ, will serve as a control group.
Design:
This experiment employs a mixed-measures, counter-balanced design. Participants will complete
two measures of reward processing (i.e. the revised monetary incentive delay (MID) task and a
temporal difference error task (TDE/juice) task) while undergoing BOLD EPI fMRI. The scanning
procedure will be repeated for all subjects, such that each participant undertakes 2
sessions. Cocaine-dependent individuals will receive either two injections of cocaine (30
mg/70 kg body weight; intravenous (IV) administration) or two injections of saline during
scanning. Within each session, each IV injection will be given approximately 10 minute prior
to the start of one of the reward measures. The order of cocaine and saline scans will be
randomized and participants will be blind to the experimental condition prior to
participation.
Outcome Measures:
The primary outcome measures will be the neural substrates of reward processing and how these
differ between cocaine-dependent individuals and controls, and the impact of acute cocaine
administration upon brain function associated with reward function.
;
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04994821 -
tDCS to Reduce Craving in Cocaine Addiction- Phase 2 Study
|
Phase 2 | |
Completed |
NCT01601743 -
Exercise as a Behavioral Treatment for Cocaine Dependence
|
N/A | |
Completed |
NCT01402492 -
Cocaine Use Reduction With Buprenorphine
|
Phase 2/Phase 3 | |
Completed |
NCT01176591 -
HBPL Study of the Impact of the NK1 Antagonist Aprepitant
|
Phase 2 | |
Completed |
NCT00880997 -
The Efficacy of Doxazosin for Cocaine Users
|
Phase 1 | |
Completed |
NCT00566969 -
Cocaine Withdrawal and Pharmacotherapy Response
|
N/A | |
Completed |
NCT00585520 -
Sex Differences in Progesterone Effects on Responses to Stress and Drug Cues
|
Phase 1 | |
Completed |
NCT00368290 -
Modafinil Treatment for Cocaine Dependence and HIV High-Risk Behavior
|
Phase 2 | |
Completed |
NCT00322309 -
Efficacy of Mirtazapine in Depressed Cocaine Dependent Subjects
|
Phase 2 | |
Completed |
NCT00385801 -
Study of the Effects of Risperdal Consta on Brain Reward Circuitry Function, Craving and Cocaine Use in Active Cocaine Dependence
|
Phase 2 | |
Completed |
NCT00167245 -
Topiramate for Alcohol and Cocaine Dependence
|
Phase 2 | |
Completed |
NCT00842517 -
Long Term Maintenance of Drug Abstinence
|
Phase 1 | |
Not yet recruiting |
NCT05974202 -
rTMS and Cognitive-behavioral Therapy for Cocaine Use Disorder
|
Phase 2 | |
Completed |
NCT04411914 -
Pharmaco-Magnetic Resonance Spectroscopy (MRS) Study of Clavulanic Acid
|
Phase 1 | |
Active, not recruiting |
NCT03266939 -
Rebalancing the Serotonergic System in Cocaine Dependence
|
Phase 1 | |
Completed |
NCT02563769 -
Clavulanic Acid (CLAV) and Cocaine Interaction Safety Study
|
Phase 1 | |
Recruiting |
NCT06159387 -
Randomized, Double-blind, Placebo-controlled Cannabis Extract x Placebo for Cocaine Addicts
|
Phase 4 | |
Terminated |
NCT02935101 -
Effects of Glucocorticoids on Craving During Detoxification Treatment of Heroin and/or Stimulants
|
Phase 2 | |
Completed |
NCT02018263 -
Validation of a Remote Wireless Sensor Network (WSN) Approach to the Individualized Detection of Cocaine Use in Humans
|
Phase 1 | |
Completed |
NCT01573273 -
Oxytocin in Cocaine Dependence
|
N/A |